160 related articles for article (PubMed ID: 22665544)
1. Systemic retinoid therapy for chemoprevention of nonmelanoma skin cancer in a patient treated with vemurafenib.
Anforth R; Blumetti TC; Mohd Affandi A; Fernandez-Penas P
J Clin Oncol; 2012 Jul; 30(19):e165-7. PubMed ID: 22665544
[No Abstract] [Full Text] [Related]
2. Vemurafenib-related cutaneous side effects ameliorated by acitretin.
Chon SY; Sambrano BL; Geddes ER
J Drugs Dermatol; 2014 May; 13(5):586-8. PubMed ID: 24809883
[TBL] [Abstract][Full Text] [Related]
3. Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors.
Anforth R; Blumetti TC; Clements A; Kefford R; Long GV; Fernandez-Peñas P
Br J Dermatol; 2013 Dec; 169(6):1310-3. PubMed ID: 23870055
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects.
Otley CC; Stasko T; Tope WD; Lebwohl M
Dermatol Surg; 2006 Apr; 32(4):562-8. PubMed ID: 16681667
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
LaPresto L; Cranmer L; Morrison L; Erickson CP; Curiel-Lewandrowski C
JAMA Dermatol; 2013 Mar; 149(3):279-81. PubMed ID: 23552479
[No Abstract] [Full Text] [Related]
6. Role of retinoids in skin cancer treatment and prevention.
Levine N
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S62-6. PubMed ID: 9703126
[No Abstract] [Full Text] [Related]
7. Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
Konda S; Patel VA; O'Bryan KW; Ratner D
Dermatol Surg; 2014 Jul; 40(7):807-10. PubMed ID: 24927001
[No Abstract] [Full Text] [Related]
8. Nonmelanoma skin cancer chemoprevention.
Prado R; Francis SO; Mason MN; Wing G; Gamble RG; Dellavalle R
Dermatol Surg; 2011 Nov; 37(11):1566-78. PubMed ID: 21895847
[No Abstract] [Full Text] [Related]
9. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
De Graaf YG; Euvrard S; Bouwes Bavinck JN
Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
Kadakia KC; Barton DL; Loprinzi CL; Sloan JA; Otley CC; Diekmann BB; Novotny PJ; Alberts SR; Limburg PJ; Pittelkow MR
Cancer; 2012 Apr; 118(8):2128-37. PubMed ID: 21882176
[TBL] [Abstract][Full Text] [Related]
11. Targeting the adnexal epithelium: an unusual case of syringometaplasia in a patient on vemurafenib.
Yu J; Ravikumar S; Plaza JA; Troy JL; Schieke SM
Am J Dermatopathol; 2015 May; 37(5):e57-60. PubMed ID: 25839889
[TBL] [Abstract][Full Text] [Related]
12. Acitretin suppression of squamous cell carcinoma: case report and literature review.
Lebwohl M; Tannis C; Carrasco D
J Dermatolog Treat; 2003; 14 Suppl 2():3-6. PubMed ID: 14578092
[TBL] [Abstract][Full Text] [Related]
13. Multiple eruptive squamous cell carcinoma in a patient with chronic plaque psoriasis on adalimumab.
Simpkin S; Oakley A
Australas J Dermatol; 2013 Feb; 54(1):55-8. PubMed ID: 22758905
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of epitheliomas].
Revenga Arranz F
Rev Clin Esp; 1997 Dec; 197(12):841-6. PubMed ID: 9477677
[No Abstract] [Full Text] [Related]
15. Acitretin for hypertrophic lichen planus-like reaction in a burn scar.
Kossard S; Artemi P
Arch Dermatol; 2000 May; 136(5):591-4. PubMed ID: 10815851
[No Abstract] [Full Text] [Related]
16. Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma.
Alonso-Castro L; Ríos-Buceta L; Vano-Galvan S; Moreno C; Soria-Rivas A; Jaén P
J Am Acad Dermatol; 2013 Jul; 69(1):e28-9. PubMed ID: 23768302
[No Abstract] [Full Text] [Related]
17. Systemic retinoids: chemoprevention of skin cancer in transplant recipients.
Hardin J; Mydlarski PR
Skin Therapy Lett; 2010; 15(7):1-4. PubMed ID: 20700551
[TBL] [Abstract][Full Text] [Related]
18. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Nemer KM; Council ML
Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723
[TBL] [Abstract][Full Text] [Related]
19. Serum Sirolimus Level Elevation Induced by Acitretin: Report of a Novel Drug-Drug Interaction.
Rossi AM; Hibler BP; Johnson-Jahangir H
J Drugs Dermatol; 2015 Jul; 14(7):747-9. PubMed ID: 26151793
[TBL] [Abstract][Full Text] [Related]
20. Retinoid chemoprevention in the high-risk patient.
DiGiovanna JJ
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S82-5. PubMed ID: 9703130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
